|
1
|
23P Impact of PDL1 expression on outcomes of patients with EGFR mutant NSCLC treated with EGFR TKIs: First results of the POET study. J Thorac Oncol 2023. [DOI: 10.1016/s1556-0864(23)00277-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/04/2023]
|
|
2
|
1618P Impact of body composition phenotypes on outcome of non-small cell lung cancer patients treated with immunotherapy. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1921] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
|
3
|
EP10.01-011 Prognostic Impact of Body Composition Phenotypes in Non-small Cell Lung Cancer Patients Receiving First-Line Pembrolizumab. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.888] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
|
4
|
1080P Immune checkpoint blockade therapy affects circulating FLIP-expressing monocytic myeloid-derived suppressor cells (M-MDSC) in non-progressor non-small cell lung cancer patients. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1206] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
|
5
|
1355P Clinical trial enrollment among lung cancer patients: A real-world multicenter analysis. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1487] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
|
6
|
1857P Choose health, oncological patients centered exercise (CHOiCE): Preliminary findings of a pilot randomized controlled trial. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.744] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
|
7
|
1640P Impact of COVID-19 vaccination campaign on psychological status in cancer patients (pts). Ann Oncol 2021. [PMCID: PMC8454306 DOI: 10.1016/j.annonc.2021.08.1633] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
|
8
|
1675P Potential effect of adipose tissue distribution on clinical outcomes in advanced non-small cell lung cancer (NSCLC) patients (pts) receiving first-line pembrolizumab (PEMBRO). Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1647] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
|
9
|
Body composition as a modulator of response to immunotherapy in lung cancer: time to deal with it. ESMO Open 2021; 6:100095. [PMID: 33773420 PMCID: PMC8027687 DOI: 10.1016/j.esmoop.2021.100095] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2021] [Revised: 02/23/2021] [Accepted: 02/24/2021] [Indexed: 12/27/2022] Open
|
|
10
|
P35.14 NGS-Based Molecular Profiling of ‘Quadruple-Negative’ (EGFR/KRAS/ALK/ROS1) Advanced Non-Small-Cell Lung Cancer (aNSCLC). J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.715] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
|
11
|
Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface. ESMO Open 2021; 6:100028. [PMID: 33465742 PMCID: PMC7814107 DOI: 10.1016/j.esmoop.2020.100028] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2020] [Accepted: 11/24/2020] [Indexed: 12/20/2022] Open
|
|
12
|
1831P Role of body composition (bc) in advanced non-small cell lung cancer (NSCLC) patients receiving first-line pembrolizumab (pembro). Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.1478] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
|
13
|
The regorafenib issue: focus on efficacy and safety in pre-treated metastatic colorectal cancer from a real world experience. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx422.044] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
|
14
|
Efficacy and safety of immune checkpoint inhibitor nivolumab and radiotherapy combination in advanced NSCLC. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx426.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
|
15
|
Bone pain control in Castration resistant prostate cancer (CRPC): retrospective analysis of first patients trated with Radium 223. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx423.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
|
16
|
Estrogen receptor mutation: a new strategy to overcome endocrine resistance. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx424.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
|
17
|
Efficacy of anti-EGFR antibodies combined with chemotherapy for elderly patients with RAS wild-type metastatic colorectal cancer: a systematic review and metanalysis. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx422.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
|
18
|
Efficacy of anti-EGFR antibodies combined with chemotherapy for elderly patients with RAS wild-type metastatic colorectal cancer: A systematic review and metanalysis. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx393.051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
|
19
|
|
|
20
|
Multidisciplinary management in ovarian cancer. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw338.09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
|
21
|
BRAF mutation and Microsatellite status in stage II and III colorectal cancers: does the combination have a prognostic role? Ann Oncol 2016. [DOI: 10.1093/annonc/mdw335.16] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
|
22
|
Trastuzumab plus chemotherapy in the treatment of HER-2 –positive, advanced, gastric or gastro-esophageal junction cancer: a single center experience. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw333.37] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
|
23
|
The impact of nutritional support in head and neck cancer patients treated with chemoradiation therapy. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv342.17] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
|
24
|
Multigene prognostic and predictive tests in Luminal breast cancer patients: relation between Mammaprint® results and nodal status in a retrospectively monocentric analysis. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv336.29] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|